OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Angiotensin Receptor Blockers Are Associated With a Lower Risk of Progression From Mild Cognitive Impairment to Dementia
Zhenhong Deng, Jingru Jiang, Jia Wang, et al.
Hypertension (2022) Vol. 79, Iss. 10, pp. 2159-2169
Open Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

The Alzheimer's Disease Neuroimaging Initiative in the era of Alzheimer's disease treatment: A review of ADNI studies from 2021 to 2022
Dallas P. Veitch, Michael W. Weiner, Melanie J. Miller, et al.
Alzheimer s & Dementia (2023) Vol. 20, Iss. 1, pp. 652-694
Open Access | Times Cited: 35

ACE-Inhibitors in Hypertension: A Historical Perspective and Current Insights
Stacey Cutrell, Ibrahim S. Alhomoud, Anurag Mehta, et al.
Current Hypertension Reports (2023) Vol. 25, Iss. 9, pp. 243-250
Closed Access | Times Cited: 32

The Renin Angiotensin System as a Therapeutic Target in Traumatic Brain Injury
Sonia Villapol, Zachary C. Janatpour, Kwame Ofori Affram, et al.
Neurotherapeutics (2023) Vol. 20, Iss. 6, pp. 1565-1591
Open Access | Times Cited: 20

Present and future of drug therapy in hypertension: an overview
Josep Redón, Rafael Carmena
Blood Pressure (2024) Vol. 33, Iss. 1
Open Access | Times Cited: 6

Angiotensin Receptor Blockers and Cognition: a Scoping Review
Zhen Zhou, Suzanne G. Orchard, Mark Nelson, et al.
Current Hypertension Reports (2023) Vol. 26, Iss. 1, pp. 1-19
Open Access | Times Cited: 13

Trajectory of Cardiogenic Dementia: A New Perspective
Nawaf AlRawili, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Journal of Cellular and Molecular Medicine (2025) Vol. 29, Iss. 2
Open Access

Angiotensin-(1-7) protective effects in neurocognitive disorders: molecular mechanisms to therapeutic implications
Lillia Lucas, Katherine Kimbark, Victoria Vernail, et al.
Frontiers in Physiology (2025) Vol. 16
Open Access

Acute Myocardial Infarction and Risk of Cognitive Impairment and Dementia: A Review
Elizabeth Thong, Joo Wei Ethan Quek, Jing Hong Loo, et al.
Biology (2023) Vol. 12, Iss. 8, pp. 1154-1154
Open Access | Times Cited: 11

A Correlative Relationship Between Heart Failure and Cognitive Impairment: A Narrative Review
Myung Soo Park, Eung Ju Kim
Journal of Korean Medical Science (2023) Vol. 38, Iss. 39
Open Access | Times Cited: 10

Diverse biological functions of the renin‐angiotensin system
Adithi Rao, Shabir Ahmad Bhat, Tomohiro Shibata, et al.
Medicinal Research Reviews (2023) Vol. 44, Iss. 2, pp. 587-605
Open Access | Times Cited: 10

Deciphering mechanisms of action of ACE inhibitors in neurodegeneration using Drosophila models of Alzheimer’s disease
Judy Ghalayini, Gabrielle L. Boulianne
Frontiers in Neuroscience (2023) Vol. 17
Open Access | Times Cited: 6

Systemic hypertension in adults with congenital heart diseases
Jolanda Sabatino, Martina Avesani, Domenico Sirico, et al.
International Journal of Cardiology Congenital Heart Disease (2023) Vol. 13, pp. 100456-100456
Open Access | Times Cited: 5

Nanoparticle approaches for the renin-angiotensin system
Sajini D. Hettiarachchi, Young Min Kwon, Yadollah Omidi, et al.
Heliyon (2023) Vol. 9, Iss. 6, pp. e16951-e16951
Open Access | Times Cited: 5

Potential molecular pathways of angiotensin receptor blockers in the brain toward cognitive improvement in dementia
Varnita Karmakar, Bapi Gorain
Drug Discovery Today (2023) Vol. 29, Iss. 1, pp. 103850-103850
Closed Access | Times Cited: 3

Autoregulation: mediators and renin–angiotensin system in diseases and treatments
Antony Sameh Mansour
Future Journal of Pharmaceutical Sciences (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 2

Age-Related Effects of AT1 Receptor Antagonist Losartan on Cognitive Decline in Spontaneously Hypertensive Rats
Jana Tchekalarova, Petja Ivanova, Desislava Krushovlieva
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7340-7340
Open Access

Anti-Hypertensives Reduce the Rate of Alzheimer’s Disease Progression: A Cohort Study Linked with Genetic and Neuropathological Analyses
Zohara Sternberg, R. Podolsky, Jihnhee Yu, et al.
The Journal of Prevention of Alzheimer s Disease (2024)
Open Access

Antihypertensive medications and dementia in older adults with hypertension
Suzanne G. Orchard, Zhen Zhou, Michelle A. Fravel, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access

Exerkine irisin mitigates cognitive impairment by suppressing gut-brain axis-mediated inflammation
Hu Zhang, Jiling Liang, Jielun Huang, et al.
Journal of Advanced Research (2024)
Open Access

Neuronal ACE1 knockout disrupts the hippocampal renin angiotensin system leading to memory impairment and vascular loss in normal aging
Sohee Jeon, Miranda A. Salvo, Alia O. Alia, et al.
Neurobiology of Disease (2024) Vol. 202, pp. 106729-106729
Open Access

The role of ACE inhibitors and ARBs in preserving cognitive function via hypertension Management: A critical Update
Sabina Yasmin, Sumel Ashique, Tahreen Taj, et al.
Brain Research (2024), pp. 149400-149400
Closed Access

Page 1 - Next Page

Scroll to top